If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

Share Price is delayed by 15 minutes
Get Live Data
62.00    0.20 (0.32%)
Bid:
61.60
Ask:
62.00
Spread: 0.40 (0.649%)
Market Cap: £2.47b
OMU Live PriceLast checked at - London Stock Exchange

Intraday Old Mutual Lim. Share Chart

Trading Statement

5 Mar 2025 07:00

RNS Number : 3550Z
Old Mutual Limited
05 March 2025
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

JSE Share Code: OMLI

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

(Old Mutual or Group)

 

Ref: 04/25

5 March 2025

 

OLD MUTUAL TRADING STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2024

 

Investors are advised that Old Mutual is currently in the process of finalising its results for the year ended 31 December 2024, which will be released on the Stock Exchange News Service of the JSE Limited on Tuesday, 18 March 2025. This trading statement provides an indication of a range for headline earnings per ordinary share and earnings attributable to equity holders of the Group per ordinary share in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the year ended 31 December 2023.

Investors are advised that the GroupÕs key profit measures are expected to be within the ranges outlined below:

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

31 December 2024

Results for the year

ended

31 December 2023

Results from operations1

-6% to 14%

7 842 to 9 511

8 343

Results from operations per share (cents)

-3% to 17%

178.1 to 214.8

183.6

Adjusted headline earnings2

4% to 24%

6 095 to 7 268

5 861

Adjusted headline earnings per share (cents)3

7% to 27%

138.0 to 163.8

129.0

Headline earnings

10% to 30%

8 118 to 9 594

7 380

Headline earnings per share (cents)

13% to 33%

187.0 to 220.1

165.5

IFRS profit after tax attributable to equity holders of the parent

-1% to 19%

6 994 to 8 407

7 065

Basis earnings per share (cents)

1% to 21%

160.0 to 191.7

158.4

 

1 Results from operations is the primary measure of the operating business performance of the GroupÕs segments

2 Adjusted headline earnings is the GroupÕs primary profit metric

3 Adjusted headline earnings per share is defined as adjusted headline earnings divided by the weighted average number of ordinary shares adjusted to reflect the Group's Broad-Based Black Economic Empowerment shares

 

Results from operations per share, adjusted headline earnings per share, headline earnings per share and basic earnings per share growth benefited from the share repurchase programme implemented in 2024 which contributed to a reduction in the weighted average number of ordinary shares to 4 353 million at 31 December 2024 (4 459 million at 31 December 2023).

We delivered solid results from operations driven by strong performance in Old Mutual Insure, Wealth Management and Old Mutual Investments, partially offset by lower life profits in Personal Finance as well as our investment in OM Bank.

Adjusted headline earnings growth was bolstered by increased shareholder investment returns.

In the prior year, headline earnings included once-off hedging losses arising from the IFRS 17 transition which were excluded from adjusted headline earnings.

The movement between IFRS profit after tax attributable to equity holders of the parent and headline earnings was primarily driven by the loss recognised on the disposal of subsidiaries from the countries which we exited as well as an impairment on an investment in an associate. This was the main contributor to the higher level of growth in headline earnings relative to IFRS profit after tax attributable to equity holders of the parent.

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the GroupÕs external auditors.

 

Sandton

 

Sponsors

JSE

Equity Sponsor: Tamela Holdings (Proprietary) Limited

Debt Sponsor: Nedbank Corporate and Investment Banking, a division of Nedbank Limited

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

Enquiries

 

Investor Relations

Langa Manqele

Head of Investor Relations

 

M: +27 82 295 9840

E: investorrelations@oldmutual.com

Communications

Wendy Tlou M: +27 82 906 5008

Chief Communications

and Reputation Officer E: oldmutualnews@oldmutual.com

 

Notes to Editors

About Old Mutual

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in 12 countries. Old Mutual's primary operations are in Africa and it has a niche business in China. With over 179 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities it serves as well as broader society on the continent.

 

For further information on Old Mutual and its underlying businesses, please visit the Corporate website at www.oldmutual.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSAWRVNUORAR
Date   Source Headline
25th Apr 20233:30 pmRNSNotice of AGM and no change statement
24th Apr 202311:00 amRNSDirector/PDMR Shareholding
21st Apr 20231:45 pmRNSForm 8.3 - [Mediclinic International plc]
19th Apr 20234:00 pmRNSDirector/PDMR Shareholding
14th Apr 202311:00 amRNSRelease of Integrated Report & Investor Engagement
13th Apr 202312:30 pmRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSForm 8.3 - [Mediclinic International plc]
6th Apr 20234:40 pmRNSDirector/PDMR Shareholding
6th Apr 20232:45 pmRNSDealings in securities on behalf of ESIS
6th Apr 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Apr 202311:00 amRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20232:00 pmRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20231:00 pmRNSDealings in securities on behalf of ESOP
4th Apr 20239:00 amRNSOML BEE certificate and annual compliance report
31st Mar 20232:30 pmRNSDealings in Securities on behalf of Share Trusts
30th Mar 202312:15 pmRNSForm 8.3 - [Mediclinic International plc]
29th Mar 20232:30 pmRNSDealings in securities on behalf of share trusts
27th Mar 20234:15 pmRNSDealings in securities on behalf of a share trust
24th Mar 20237:00 amRNSNo change statement
22nd Mar 20238:00 amRNSFINALISATION AND DIVIDEND CURRENCY EQUIVALENTS
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20233:15 pmRNSDealings in securities on behalf of share trusts
17th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
16th Mar 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
15th Mar 202312:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20237:00 amRNSFinal Results
10th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
9th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
8th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
3rd Mar 202310:00 amRNSForm 8.3 - [Mediclinic International plc]
2nd Mar 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
24th Feb 20237:00 amRNSVoluntary Trading Statement
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding Correction
22nd Feb 20233:30 pmRNSDirector/PDMR Shareholding
7th Feb 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
3rd Feb 20231:00 pmRNSForm 8.3 - [Mediclinic International plc]
27th Jan 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
10th Jan 202311:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Jan 202312:00 pmRNSForm 8.3 - Mediclinic International plc
21st Dec 20221:00 pmRNSForm 8.3 - [Mediclinic International plc]
16th Dec 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 20221:50 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 202211:30 amRNSForm 8.3 - Micro Focus International plc
30th Nov 202212:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Nov 20227:00 amRNSVoluntary Operating Update
21st Nov 20223:00 pmRNSImplementation of the Bula Tsela transaction
18th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
17th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
16th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.